Literature DB >> 25002342

Validation of the Spanish version of Addenbrooke's Cognitive Examination III for diagnosing dementia.

J A Matias-Guiu1, R Fernández de Bobadilla2, G Escudero3, J Pérez-Pérez2, A Cortés3, E Morenas-Rodríguez2, M Valles-Salgado3, T Moreno-Ramos3, J Kulisevsky2, J Matías-Guiu3.   

Abstract

INTRODUCTION: Addenbrooke's Cognitive Examination is a screening test used to diagnose dementia. The third edition of this test (ACE-III) was recently developed. The aim of this study was to translate and validate the ACE-III in Spanish.
METHODS: The ACE-III was translated and adapted to Spanish. It was then administered to a group of healthy subjects as well as a group of patients with different types of mild dementia treated in 2 hospitals in Spain.
RESULTS: Internal reliability (Cronbach's alpha = 0.927), inter-rater reliability (intraclass correlation coefficient = 0.976) and test-retest reliability (kappa 0.995) were excellent. Age (r = -0.512) and education (r = 0.659) showed a significant correlation with total test scores. The diagnostic accuracy of ACE-III was higher than that of the Mini-Mental State Examination, particularly for the group with the highest educational level. Researchers obtained normative data and cut-off points for the diagnosis of dementia.
CONCLUSIONS: The Spanish version of the ACE-III is a reliable and valid test for diagnosing dementia. Its diagnostic accuracy is high, especially in patients with a higher level of education.
Copyright © 2014 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Addenbrooke's Cognitive Examination; Alzheimer disease; Cognitive screening; Cribado cognitivo; Demencia; Demencia frontotemporal; Dementia; Enfermedad de Alzheimer; Evaluación neuropsicológica; Frontotemporal dementia; Neuropsychological assessment

Mesh:

Year:  2014        PMID: 25002342     DOI: 10.1016/j.nrl.2014.05.004

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  11 in total

1.  Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis.

Authors:  Jordi A Matías-Guiu; Vanesa Pytel; María Nieves Cabrera-Martín; Lucía Galán; María Valles-Salgado; Antonio Guerrero; Teresa Moreno-Ramos; Jorge Matías-Guiu; José Luis Carreras
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-04       Impact factor: 9.236

2.  Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.

Authors:  Carlos Calderón; Christian Beyle; Oscar Véliz-García; Juan Bekios-Calfa
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

Review 3.  Addenbrooke's cognitive examination III in the diagnosis of dementia: a critical review.

Authors:  Diana Bruno; Sofia Schurmann Vignaga
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-15       Impact factor: 2.570

4.  Validation of Addenbrooke's cognitive examination III for detecting mild cognitive impairment and dementia in Japan.

Authors:  Shintaro Takenoshita; Seishi Terada; Hidenori Yoshida; Megumi Yamaguchi; Mayumi Yabe; Nao Imai; Makiko Horiuchi; Tomoko Miki; Osamu Yokota; Norihito Yamada
Journal:  BMC Geriatr       Date:  2019-04-29       Impact factor: 3.921

5.  Validation of the Malay Version of Addenbrooke's Cognitive Examination III in Detecting Mild Cognitive Impairment and Dementia.

Authors:  Kwai Ching Kan; Ponnusamy Subramaniam; Nortina Shahrizaila; Shahrul Bahyah Kamaruzzaman; Rosdinom Razali; Shazli Ezzat Ghazali
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2019-02-08

6.  Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment.

Authors:  Bian-Rong Wang; Hui-Fen Zheng; Chang Xu; Yi Sun; Ying-Dong Zhang; Jian-Quan Shi
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-13       Impact factor: 2.570

7.  Guideline-conform translation and cultural adaptation of the Addenbrooke's Cognitive Examination III into German.

Authors:  Björn Weiss; Julius J Grunow; Max Rosenthal; David Hilfrich; Rudolf Mörgeli; Bruno Neuner; Friedrich Borchers; Antje Kraft; Henning Krampe; Claudia Denke; Claudia D Spies
Journal:  Ger Med Sci       Date:  2020-04-06

8.  Reporting of the translation and cultural adaptation procedures of the Addenbrooke's Cognitive Examination version III (ACE-III) and its predecessors: a systematic review.

Authors:  Nadine Mirza; Maria Panagioti; Muhammad Wali Waheed; Waquas Waheed
Journal:  BMC Med Res Methodol       Date:  2017-09-13       Impact factor: 4.615

9.  Comparing Sensitivity and Specificity of Addenbrooke's Cognitive Examination-I, III and Mini-Addenbrooke's Cognitive Examination in Parkinson's Disease.

Authors:  Tivadar Lucza; Zsuzsanna Ascherman; Márton Kovács; Attila Makkos; Márk Harmat; Annamária Juhász; József Janszky; Sámuel Komoly; Norbert Kovács; Krisztina Dorn; Kázmér Karádi
Journal:  Behav Neurol       Date:  2018-10-02       Impact factor: 3.342

10.  Hindi Version of Addenbrooke's Cognitive Examination III: Distinguishing Cognitive Impairment Among Older Indians at the Lower Cut-Offs.

Authors:  Swati Bajpai; Ashish Upadhyay; Hemchand Sati; R M Pandey; Prasun Chaterjee; A B Dey
Journal:  Clin Interv Aging       Date:  2020-03-05       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.